{"originalText": "，患者2006-11无明显诱因便血2周，，外院肠镜示：至肛门2-3CM肿物，直肠中分化腺癌。2006-11在我院行MILES术，病理示中分化腺癌，浸润深肌层，淋巴结0/3，脉管内见癌栓，PT2N0M0，I期.术后于2007-05至2008-01-28行XELODA单药化疗4程。后定期复查。，2013-03-26复查CT：两肺转移；纵隔及两肺门多发淋巴结转移；腹主动脉及两髂血管旁多发淋巴结转移。，肺部病灶穿刺活检示：中分化腺癌，提示肠癌转移可能性大。遂于2013-04-27至2013-10-09在我科行一线FOLFOX方案化疗9程，3程后评价SD，6程后评价PR，9程后评价PD。患者拟参加阿柏西普临床试验，因血小板偏低，不符合入组筛选条件。2013-11-04行二线CPT-11单药化疗1程，11-27、2013-12-17、1-3行CPT-11+安维汀化疗3程，4程化疗后CT评价示SD。下程化疗后出现I度呕吐，经对症处理后恢复。现为继续上程化疗收入院。现患者一般情况可，大小便正常，体重无明显变化。", "entities": [{"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 38, "end_pos": 45}, {"end_pos": 63, "label_type": "手术", "overlap": 0, "start_pos": 57}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 67, "end_pos": 72}, {"end_pos": 132, "label_type": "药物", "overlap": 0, "start_pos": 126}, {"label_type": "影像检查", "overlap": 0, "start_pos": 158, "end_pos": 160}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 161, "end_pos": 165}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 209, "end_pos": 214}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 217, "end_pos": 219}, {"end_pos": 301, "label_type": "药物", "overlap": 0, "start_pos": 297}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"end_pos": 342, "label_type": "药物", "overlap": 0, "start_pos": 336}, {"end_pos": 376, "label_type": "药物", "overlap": 0, "start_pos": 370}, {"end_pos": 380, "label_type": "药物", "overlap": 0, "start_pos": 377}, {"label_type": "影像检查", "overlap": 0, "start_pos": 390, "end_pos": 392}]}
